Variant report
Variant | nsv521025 |
---|---|
Chromosome Location | chr17:20198024-20514921 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1763)
- CpG islands (count:2931)
- Chromatin interactive region (count:3)
- LncRNA region (count:51)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr17:20224178-20224437 | K562 | blood: | n/a | n/a |
2 | ATF3 | chr17:20224059-20224450 | H1-hESC | embryonic stem cell: | n/a | chr17:20224408-20224418 chr17:20224410-20224430 chr17:20224408-20224421 chr17:20224409-20224420 chr17:20224410-20224421 chr17:20224409-20224420 chr17:20224408-20224418 chr17:20224409-20224422 chr17:20224408-20224421 chr17:20224411-20224421 chr17:20224410-20224418 chr17:20224411-20224418 chr17:20224411-20224421 chr17:20224411-20224419 chr17:20224407-20224422 |
3 | BACH1 | chr17:20388438-20388633 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | BATF | chr17:20370787-20371117 | GM12878 | blood: | n/a | n/a |
5 | BATF | chr17:20443708-20444186 | GM12878 | blood: | n/a | n/a |
6 | BATF | chr17:20255920-20256169 | GM12878 | blood: | n/a | n/a |
7 | BATF | chr17:20268534-20268812 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr17:20443556-20444223 | GM12878 | blood: | n/a | n/a |
9 | BATF | chr17:20248455-20248916 | GM12878 | blood: | n/a | n/a |
10 | BATF | chr17:20449270-20449503 | GM12878 | blood: | n/a | n/a |
11 | BATF | chr17:20339552-20339955 | GM12878 | blood: | n/a | chr17:20339773-20339784 chr17:20339774-20339784 |
12 | BATF | chr17:20354345-20354597 | GM12878 | blood: | n/a | chr17:20354476-20354487 |
13 | BATF | chr17:20243234-20243495 | GM12878 | blood: | n/a | n/a |
14 | BATF | chr17:20354311-20354673 | GM12878 | blood: | n/a | chr17:20354476-20354487 |
15 | BATF | chr17:20284594-20284865 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr17:20370764-20371076 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr17:20339605-20339854 | GM12878 | blood: | n/a | chr17:20339773-20339784 chr17:20339774-20339784 |
18 | BATF | chr17:20268484-20268863 | GM12878 | blood: | n/a | n/a |
19 | BATF | chr17:20224099-20224508 | GM12878 | blood: | n/a | n/a |
20 | BCL11A | chr17:20372530-20372862 | GM12878 | blood: | n/a | n/a |
21 | BCL11A | chr17:20370806-20371041 | GM12878 | blood: | n/a | n/a |
22 | BCL11A | chr17:20224157-20224416 | GM12878 | blood: | n/a | n/a |
23 | BCL11A | chr17:20370709-20371057 | GM12878 | blood: | n/a | n/a |
24 | BCL11A | chr17:20224116-20224588 | GM12878 | blood: | n/a | n/a |
25 | BCL11A | chr17:20326172-20326448 | GM12878 | blood: | n/a | n/a |
26 | BCL11A | chr17:20443676-20444145 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr17:20268605-20268835 | GM12878 | blood: | n/a | n/a |
28 | BCL11A | chr17:20371063-20371231 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr17:20443777-20444111 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr17:20243128-20243463 | GM12878 | blood: | n/a | n/a |
31 | BCL3 | chr17:20438566-20438789 | GM12878 | blood: | n/a | n/a |
32 | BHLHE40 | chr17:20285598-20285614 | K562 | blood: | n/a | n/a |
33 | BHLHE40 | chr17:20514794-20515059 | K562 | blood: | n/a | chr17:20514926-20514939 chr17:20514929-20514938 chr17:20514928-20514937 |
34 | BHLHE40 | chr17:20354420-20354612 | K562 | blood: | n/a | n/a |
35 | BRCA1 | chr17:20224169-20224376 | H1-hESC | embryonic stem cell: | n/a | n/a |
36 | BRCA1 | chr17:20224258-20224346 | HepG2 | liver: | n/a | n/a |
37 | CBX3 | chr17:20224068-20224528 | K562 | blood: | n/a | n/a |
38 | CBX3 | chr17:20210305-20210555 | K562 | blood: | n/a | n/a |
39 | CBX3 | chr17:20224147-20224397 | K562 | blood: | n/a | n/a |
40 | CEBPB | chr17:20469063-20469069 | K562 | blood: | n/a | n/a |
41 | CEBPB | chr17:20200541-20200898 | A549 | lung: | n/a | chr17:20200701-20200712 |
42 | CEBPB | chr17:20211603-20211937 | HepG2 | liver: | n/a | chr17:20211782-20211793 |
43 | CEBPB | chr17:20200621-20200824 | K562 | blood: | n/a | chr17:20200701-20200712 |
44 | CEBPB | chr17:20474419-20474705 | HepG2 | liver: | n/a | chr17:20474573-20474584 |
45 | CEBPB | chr17:20243727-20243984 | K562 | blood: | n/a | chr17:20243922-20243935 |
46 | CEBPB | chr17:20432904-20432946 | K562 | blood: | n/a | n/a |
47 | CEBPB | chr17:20211638-20211964 | A549 | lung: | n/a | chr17:20211782-20211793 |
48 | CEBPB | chr17:20224268-20224483 | A549 | lung: | n/a | n/a |
49 | CEBPB | chr17:20432902-20433054 | IMR90 | lung: | n/a | chr17:20432946-20432955 chr17:20432944-20432957 chr17:20432944-20432955 |
50 | CEBPB | chr17:20468918-20469141 | HepG2 | liver: | n/a | chr17:20469062-20469073 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:20456385-20456435 | LNCaP | prostate: | n/a |
2 | chr17:20456901-20456951 | T-47D | breast: | n/a |
3 | chr17:20409125-20409175 | HepG2 | liver: | n/a |
4 | chr17:20456385-20456435 | LNCaP | prostate: | n/a |
5 | chr17:20456901-20456951 | T-47D | breast: | n/a |
6 | chr17:20409125-20409175 | HepG2 | liver: | n/a |
7 | chr17:20203992-20204042 | MCF10A-Er-Src | breast: | n/a |
8 | chr17:20450466-20450516 | Hela-S3 | cervix: | n/a |
9 | chr17:20460627-20460677 | NB4 | blood: | n/a |
10 | chr17:20339878-20339928 | BE2_C | brain: | n/a |
11 | chr17:20433187-20433237 | Hepatocyte | liver: | n/a |
12 | chr17:20467965-20468015 | GM19239 | blood: | n/a |
13 | chr17:20456385-20456435 | PFSK-1 | brain: | n/a |
14 | chr17:20467917-20467967 | HCM | heart: | n/a |
15 | chr17:20224230-20224280 | U87 | brain: | n/a |
16 | chr17:20465437-20465487 | AG10803 | skin: | n/a |
17 | chr17:20279144-20279194 | Hepatocyte | liver: | n/a |
18 | chr17:20450466-20450516 | GM12878 | blood: | n/a |
19 | chr17:20408772-20408822 | HepG2 | liver: | n/a |
20 | chr17:20445757-20445807 | NH-A | brain: | n/a |
21 | chr17:20467965-20468015 | A549 | lung: | n/a |
22 | chr17:20492631-20492681 | HAEpiC | amniotic membrane: | n/a |
23 | chr17:20225674-20225724 | A549 | lung: | n/a |
24 | chr17:20217823-20217873 | PANC-1 | pancreas: | n/a |
25 | chr17:20280153-20280203 | ECC-1 | luminal epithelium: | n/a |
26 | chr17:20346491-20346541 | SK-N-SH_RA | brain: | n/a |
27 | chr17:20326541-20326591 | HEEpiC | esophagus: | n/a |
28 | chr17:20492631-20492681 | ECC-1 | luminal epithelium: | n/a |
29 | chr17:20467917-20467967 | Caco-2 | colon: | n/a |
30 | chr17:20445757-20445807 | GM19239 | blood: | n/a |
31 | chr17:20408772-20408822 | HCM | heart: | n/a |
32 | chr17:20480574-20480624 | Caco-2 | colon: | n/a |
33 | chr17:20456385-20456435 | NT2-D1 | testis: | n/a |
34 | chr17:20445757-20445807 | GM12891 | blood: | n/a |
35 | chr17:20460588-20460638 | GM06990 | blood: | n/a |
36 | chr17:20224230-20224280 | MCF-7 | breast: | n/a |
37 | chr17:20433187-20433237 | SK-N-SH_RA | brain: | n/a |
38 | chr17:20224414-20224464 | SAEC | small airway: | n/a |
39 | chr17:20339589-20339639 | AG04450 | lung: | fetal |
40 | chr17:20224345-20224395 | H1-hESC | embryonic stem cell: | embryo |
41 | chr17:20493386-20493436 | HEEpiC | esophagus: | n/a |
42 | chr17:20408647-20408697 | Hepatocyte | liver: | n/a |
43 | chr17:20489071-20489121 | PFSK-1 | brain: | n/a |
44 | chr17:20454132-20454182 | SK-N-SH_RA | brain: | n/a |
45 | chr17:20460588-20460638 | AG04449 | skin: | fetal |
46 | chr17:20448558-20448608 | HNPCEpiC | eye: | n/a |
47 | chr17:20464366-20464416 | Jurkat | blood: | n/a |
48 | chr17:20448558-20448608 | GM19239 | blood: | n/a |
49 | chr17:20480574-20480624 | HRPEpiC | eye: | n/a |
50 | chr17:20448558-20448608 | AG09319 | gingival: | n/a |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LGALS9B-2 | chr17:20479798-20480107 | XLOC_012419 |
2 | lnc-FAM106B-1 | chr17:20320763-20321272 | NONHSAT146571 |
3 | lnc-CCDC144C-1 | chr17:20265497-20265680 | NR_023380 |
4 | lnc-FAM106B-2 | chr17:20337350-20337598 | ENSG00000265556.1 |
5 | lnc-LGALS9B-2 | chr17:20478895-20479172 | XLOC_012419 |
6 | lnc-LGALS9B-2 | chr17:20481940-20482234 | XLOC_012419 |
7 | lnc-FAM106B-1 | chr17:20320741-20322363 | NONHSAT146570 |
8 | lnc-LGALS9B-10 | chr17:20435561-20436194 | NONHSAT146584 |
9 | lnc-LGALS9B-2 | chr17:20481940-20482234 | XLOC_012419 |
10 | lnc-FAM106B-2 | chr17:20336519-20336570 | ENSG00000265556.1 |
11 | lnc-LGALS9B-2 | chr17:20479798-20480107 | XLOC_012419 |
12 | lnc-CCDC144C-1 | chr17:20241470-20241543 | NR_023380 |
13 | lnc-CCDC144NL-9 | chr17:20355664-20355708 | NONHSAT146574 |
14 | lnc-CCDC144C-1 | chr17:20245671-20245807 | NR_023380 |
15 | lnc-LGALS9B-12 | chr17:20447359-20447436 | NONHSAT146601 |
16 | lnc-LGALS9B-1 | chr17:20433355-20434194 | ENSG00000260907.1 |
17 | lnc-CCDC144C-1 | chr17:20295677-20295897 | NR_023380 |
18 | lnc-LGALS9B-4 | chr17:20373955-20374185 | ucscGeneNc_uc002gxd_1 |
19 | lnc-LGALS9B-2 | chr17:20479798-20480255 | XLOC_012419 |
20 | lnc-LGALS9B-2 | chr17:20479980-20480210 | ENSG00000264422.1 |
21 | lnc-CCDC144C-1 | chr17:20305369-20305504 | NR_023380 |
22 | lnc-CCDC144C-1 | chr17:20294788-20295081 | NR_023380 |
23 | lnc-CCDC144C-1 | chr17:20239145-20239393 | NR_023380 |
24 | lnc-CCDC144C-1 | chr17:20254251-20254284 | NR_023380 |
25 | lnc-CCDC144NL-9 | chr17:20354914-20355028 | NONHSAT146573 |
26 | lnc-CCDC144C-1 | chr17:20268399-20269343 | NR_023380 |
27 | lnc-LGALS9B-13 | chr17:20462661-20462723 | NONHSAT146793 |
28 | lnc-LGALS9B-12 | chr17:20446287-20446510 | NONHSAT146601 |
29 | lnc-CCDC144NL-9 | chr17:20356330-20356786 | NONHSAT146574 |
30 | lnc-LGALS9B-7 | chr17:20410726-20412244 | ENSG00000266925.1 |
31 | lnc-CCDC144C-1 | chr17:20254570-20254711 | NR_023380 |
32 | lnc-CCDC144C-1 | chr17:20224487-20224973 | NR_023380 |
33 | lnc-LGALS9B-2 | chr17:20481940-20482061 | ENSG00000264422.1 |
34 | lnc-LGALS9B-4 | chr17:20375554-20376706 | ucscGeneNc_uc002gxd_1 |
35 | lnc-CCDC144C-1 | chr17:20303834-20303876 | NR_023380 |
36 | lnc-LGALS9B-2 | chr17:20481940-20482149 | XLOC_012419 |
37 | lnc-CCDC144C-1 | chr17:20266235-20266363 | NR_023380 |
38 | lnc-CCDC144C-1 | chr17:20261192-20261409 | NR_023380 |
39 | lnc-LGALS9B-12 | chr17:20446789-20446842 | NONHSAT146601 |
40 | lnc-LGALS9B-13 | chr17:20458740-20458896 | NONHSAT146793 |
41 | lnc-LGALS9B-2 | chr17:20478827-20479172 | XLOC_012419 |
42 | lnc-SPECC1-3 | chr17:20244056-20244356 | NONHSAT146561 |
43 | lnc-LGALS9B-2 | chr17:20479866-20480107 | XLOC_012419 |
44 | lnc-CCDC144NL-9 | chr17:20355108-20355484 | NONHSAT146573 |
45 | lnc-SPECC1-1 | chr17:20226197-20226286 | ENSG00000263494.1 |
46 | lnc-SPECC1-2 | chr17:20226371-20226650 | ENSG00000266839.1 |
47 | lnc-CCDC144C-1 | chr17:20227496-20227566 | NR_023380 |
48 | lnc-CCDC144C-1 | chr17:20242793-20243632 | NR_023380 |
49 | lnc-LGALS9B-2 | chr17:20478895-20479010 | XLOC_012419 |
50 | lnc-LGALS9B-13 | chr17:20459470-20459532 | NONHSAT146793 |
No data |
No data |
Variant related genes | Relation type |
---|---|
UPF3AP2 | TF binding region |
FAM106B | TF binding region |
ENSG00000263946 | TF binding region |
ENSG00000230339 | TF binding region |
ENSG00000265916 | TF binding region |
ENSG00000205215 | TF binding region |
COTL1P2 | TF binding region |
USP32P3 | TF binding region |
ENSG00000264422 | TF binding region |
ZSWIM5P2 | TF binding region |
SRP68P3 | TF binding region |
ENSG00000232889 | TF binding region |
ENSG00000229586 | TF binding region |
ENSG00000235546 | TF binding region |
ENSG00000265556 | TF binding region |
LGALS9B | TF binding region |
CDRT15L2 | TF binding region |
SPECC1 | TF binding region |
ENSG00000260907 | TF binding region |
YWHAEP3 | TF binding region |
ENSG00000266042 | TF binding region |
NOS2P3 | TF binding region |
KRT16P5 | TF binding region |
RN7SL17P | TF binding region |
ENSG00000266925 | TF binding region |
CCDC144CP | TF binding region |
ENSG00000231645 | TF binding region |
MEIS3P2 | TF binding region |
ENSG00000226096 | TF binding region |
TBC1D3P3 | TF binding region |
KRT16P3 | TF binding region |
ENSG00000266839 | TF binding region |
ENSG00000264981 | TF binding region |
ENSG00000267075 | TF binding region |
UPF3AP2 | CpG island |
FAM106B | CpG island |
ENSG00000263946 | CpG island |
ENSG00000230339 | CpG island |
ENSG00000265916 | CpG island |
ENSG00000205215 | CpG island |
COTL1P2 | CpG island |
USP32P3 | CpG island |
ENSG00000264422 | CpG island |
ZSWIM5P2 | CpG island |
SRP68P3 | CpG island |
ENSG00000232889 | CpG island |
ENSG00000229586 | CpG island |
ENSG00000235546 | CpG island |
ENSG00000265556 | CpG island |
LGALS9B | CpG island |
CDRT15L2 | CpG island |
SPECC1 | CpG island |
ENSG00000260907 | CpG island |
YWHAEP3 | CpG island |
ENSG00000266042 | CpG island |
NOS2P3 | CpG island |
KRT16P5 | CpG island |
RN7SL17P | CpG island |
ENSG00000266925 | CpG island |
CCDC144CP | CpG island |
ENSG00000231645 | CpG island |
MEIS3P2 | CpG island |
ENSG00000226096 | CpG island |
TBC1D3P3 | CpG island |
KRT16P3 | CpG island |
ENSG00000266839 | CpG island |
ENSG00000264981 | CpG island |
ENSG00000267075 | CpG island |
ENSG00000214860 | chromatin interactions |
ENSG00000252971 | chromatin interactions |
VPS4B | miRNA target sites |
RNF125 | miRNA target sites |
GTF3C4 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2034110 | chr17:20198024-20198025 | Weak transcription ZNF genes & repeats Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs66686539 | chr17:20198033-20198034 | Weak transcription ZNF genes & repeats Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs146621863 | chr17:20198087-20198088 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs370660726 | chr17:20198121-20198122 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs563023095 | chr17:20198128-20198129 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs184628137 | chr17:20198131-20198132 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs530280666 | chr17:20198136-20198137 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs11654025 | chr17:20198160-20198161 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs187641556 | chr17:20198185-20198186 | Weak transcription ZNF genes & repeats Strong transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs376378110 | chr17:20198198-20198199 | Weak transcription ZNF genes & repeats Strong transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs115819408 | chr17:20198204-20198205 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs192935976 | chr17:20198257-20198258 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs553141819 | chr17:20198290-20198291 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs141238311 | chr17:20198315-20198316 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs34174703 | chr17:20198327-20198328 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs527360380 | chr17:20198328-20198329 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550371553 | chr17:20198346-20198347 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs397728703 | chr17:20198351-20198352 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs185121777 | chr17:20198373-20198374 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs189585538 | chr17:20198430-20198431 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs12941220 | chr17:20198484-20198485 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs554341191 | chr17:20198507-20198508 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs12950564 | chr17:20198557-20198558 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
24 | rs547210216 | chr17:20198565-20198566 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs547376640 | chr17:20198574-20198575 | Weak transcription ZNF genes & repeats | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs367668567 | chr17:20198612-20198613 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs181286479 | chr17:20198623-20198624 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs62066878 | chr17:20198631-20198632 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs562798235 | chr17:20198682-20198683 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs7223481 | chr17:20198708-20198709 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs148967981 | chr17:20198737-20198738 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs557344308 | chr17:20198743-20198744 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs143705542 | chr17:20198758-20198759 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs527922501 | chr17:20198775-20198776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552572264 | chr17:20198782-20198783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs564822417 | chr17:20198785-20198786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570337940 | chr17:20198791-20198792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563336681 | chr17:20198833-20198834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs531973716 | chr17:20198846-20198847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs148249484 | chr17:20198882-20198883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs568559640 | chr17:20198885-20198886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs535932859 | chr17:20198890-20198891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs547918374 | chr17:20198927-20198928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566311183 | chr17:20198948-20198949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs373830266 | chr17:20198953-20198954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368498845 | chr17:20198997-20198998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188195235 | chr17:20199039-20199040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs570731818 | chr17:20199049-20199050 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371902887 | chr17:20199053-20199054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs142781167 | chr17:20199079-20199080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Cancer | 17440070 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20136400-20209800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr17:20164000-20200200 | Weak transcription | Fetal Intestine Large | intestine |
3 | chr17:20164000-20205600 | Weak transcription | Esophagus | oesophagus |
4 | chr17:20164200-20200200 | Weak transcription | H1 Cell Line | embryonic stem cell |
5 | chr17:20164400-20202200 | Weak transcription | Duodenum Mucosa | Duodenum |
6 | chr17:20164600-20203800 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
7 | chr17:20164600-20204000 | Weak transcription | Gastric | stomach |
8 | chr17:20167400-20200200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
9 | chr17:20170400-20209600 | Weak transcription | HMEC | breast |
10 | chr17:20171200-20200200 | Weak transcription | Lung | lung |
11 | chr17:20174400-20200200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr17:20175000-20200200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
13 | chr17:20180400-20200200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
14 | chr17:20180400-20203400 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
15 | chr17:20180600-20203200 | Weak transcription | Rectal Smooth Muscle | rectum |
16 | chr17:20181200-20200400 | Weak transcription | Adipose Nuclei | Adipose |
17 | chr17:20181400-20200400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
18 | chr17:20181400-20200400 | Weak transcription | Primary hematopoietic stem cells | blood |
19 | chr17:20182000-20203000 | Weak transcription | NH-A | brain |
20 | chr17:20182400-20200400 | Weak transcription | Osteobl | bone |
21 | chr17:20184000-20200200 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
22 | chr17:20184800-20200400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
23 | chr17:20185000-20200200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
24 | chr17:20185200-20209800 | Weak transcription | H9 Cell Line | embryonic stem cell |
25 | chr17:20185400-20203800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
26 | chr17:20185600-20201600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
27 | chr17:20185600-20206800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
28 | chr17:20185800-20203000 | Weak transcription | Duodenum Smooth Muscle | Duodenum |
29 | chr17:20186000-20203000 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
30 | chr17:20186000-20209400 | Weak transcription | Spleen | Spleen |
31 | chr17:20186200-20209800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
32 | chr17:20187800-20223800 | Weak transcription | Pancreas | Pancrea |
33 | chr17:20188000-20200200 | Weak transcription | Aorta | Aorta |
34 | chr17:20188200-20208400 | Weak transcription | NHEK | skin |
35 | chr17:20188400-20200400 | Weak transcription | HSMMtube | muscle |
36 | chr17:20188400-20205600 | Weak transcription | Primary T cells from cord blood | blood |
37 | chr17:20188600-20200200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
38 | chr17:20188600-20200200 | Weak transcription | Brain Substantia Nigra | brain |
39 | chr17:20188600-20203200 | Weak transcription | HSMM | muscle |
40 | chr17:20188600-20209800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
41 | chr17:20188600-20209800 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
42 | chr17:20188800-20203000 | Weak transcription | Fetal Stomach | stomach |
43 | chr17:20189800-20200200 | Weak transcription | Brain Angular Gyrus | brain |
44 | chr17:20190000-20208600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
45 | chr17:20190200-20200200 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
46 | chr17:20190400-20200400 | Weak transcription | Hela-S3 | cervix |
47 | chr17:20190400-20200600 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
48 | chr17:20190400-20203800 | Weak transcription | Colonic Mucosa | Colon |
49 | chr17:20190400-20204600 | Weak transcription | Right Ventricle | heart |
50 | chr17:20191600-20200200 | Weak transcription | Brain Inferior Temporal Lobe | brain |